vegf polyclonal antibody Search Results


94
Cell Applications Inc phospho vegfr 2
Phospho Vegfr 2, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc05225300-28-14-16?v=Cell+Applications+Inc
Average 94 stars, based on 1 article reviews
phospho vegfr 2 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Bioss vegf primary antibody
Vegf Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pm41787057-87-15-19?v=Bioss
Average 94 stars, based on 1 article reviews
vegf primary antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Elabscience Biotechnology anti vegf polyclonal antibody
The sequences of the designed primers
Anti Vegf Polyclonal Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc08520664-42-33-37?v=Elabscience+Biotechnology
Average 96 stars, based on 1 article reviews
anti vegf polyclonal antibody - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
OriGene rabbit antihuman vegf
The sequences of the designed primers
Rabbit Antihuman Vegf, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pm23206445-45-28-35?v=OriGene
Average 90 stars, based on 1 article reviews
rabbit antihuman vegf - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene iggs against p vegfr2
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Iggs Against P Vegfr2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pm28715845-84-18-21?v=OriGene
Average 90 stars, based on 1 article reviews
iggs against p vegfr2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene phospho vegf receptor 2 tyr1175
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Phospho Vegf Receptor 2 Tyr1175, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc05783842-182-104-102?v=OriGene
Average 90 stars, based on 1 article reviews
phospho vegf receptor 2 tyr1175 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene rabbit α flt1
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Rabbit α Flt1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc07289892__41467_2020_16768_MOESM3_ESM-33-74-77?v=OriGene
Average 90 stars, based on 1 article reviews
rabbit α flt1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene anti vegfr1
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Anti Vegfr1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc09729891-297-0-5?v=OriGene
Average 90 stars, based on 1 article reviews
anti vegfr1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
Elabscience Biotechnology rabbit anti vegf receptor 2
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Rabbit Anti Vegf Receptor 2, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pm38026676-91-0-3?v=Elabscience+Biotechnology
Average 96 stars, based on 1 article reviews
rabbit anti vegf receptor 2 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

94
Elabscience Biotechnology anti vegfr1 flt 1 antibody
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Anti Vegfr1 Flt 1 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc12999369-91-32-37?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
anti vegfr1 flt 1 antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
OriGene vegfr
FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of <t>VEGFR2</t> and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).
Vegfr, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pm20650960-286-37-39?v=OriGene
Average 90 stars, based on 1 article reviews
vegfr - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene rabbit polyclonal anti flk1 1
KEY RESOURCES TABLE
Rabbit Polyclonal Anti Flk1 1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegf+polyclonal+antibody/pmc06585464-29-0-4?v=OriGene
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti flk1 1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


The sequences of the designed primers

Journal: Journal of Family & Reproductive Health

Article Title: Effect of Lysophosphatidic Acid on the Vascular Endothelial Growth Factor Expression in Autotransplanted Mouse Ovaries Encapsulated in Sodium Alginate

doi: 10.18502/jfrh.v15i2.6449

Figure Lengend Snippet: The sequences of the designed primers

Article Snippet: The cells were permeable by putting the sections in triton X100 (0.3 % for 30 min), washed in PBS and blocked with goat serum (30 min) then, they were incubated with the primary anti-VEGF polyclonal antibody (1:100, Elabscience Biotechnology Co, Wuhan, China) overnight.

Techniques: Sequencing

The fluorescent microscopy observations of transplanted mouse ovarian tissue sections immunostained for VEGF antibody (first row) and phase contrast of the same groups in second row. A and a: Intact control group; B and b: LPA+/LPA-; C and c: LPA-/LPA-. Green color shows the positive cell reaction (white arrow) for VEGF antibody (Bar=50μm). The comparison of the relative expression ratio of Vegf gene to β- actin in transplanted mouse ovaries and intact control group are shown in parts D.

Journal: Journal of Family & Reproductive Health

Article Title: Effect of Lysophosphatidic Acid on the Vascular Endothelial Growth Factor Expression in Autotransplanted Mouse Ovaries Encapsulated in Sodium Alginate

doi: 10.18502/jfrh.v15i2.6449

Figure Lengend Snippet: The fluorescent microscopy observations of transplanted mouse ovarian tissue sections immunostained for VEGF antibody (first row) and phase contrast of the same groups in second row. A and a: Intact control group; B and b: LPA+/LPA-; C and c: LPA-/LPA-. Green color shows the positive cell reaction (white arrow) for VEGF antibody (Bar=50μm). The comparison of the relative expression ratio of Vegf gene to β- actin in transplanted mouse ovaries and intact control group are shown in parts D.

Article Snippet: The cells were permeable by putting the sections in triton X100 (0.3 % for 30 min), washed in PBS and blocked with goat serum (30 min) then, they were incubated with the primary anti-VEGF polyclonal antibody (1:100, Elabscience Biotechnology Co, Wuhan, China) overnight.

Techniques: Microscopy, Control, Comparison, Expressing

FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of VEGFR2 and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).

Journal: Investigative ophthalmology & visual science

Article Title: Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.

doi: 10.1167/iovs.17-21416

Figure Lengend Snippet: FIGURE 1. Apatinib inhibits VEGF-induced phosphorylation of VEGFR2 and ERK in HRMECs. (A) Representative Western blotting images and (B, C) densitometric analysis of phosphorylated VEGFR2 (p-VEGFR2; B) and phosphorylated ERK (p-ERK; C) are illustrated. HRMECs treated with apatinib (1 lM) and untreated cells were stimulated with rhVEGF (100 ng/mL) or PBS for 20 minutes. Cell lysates were subjected to Western blotting using primary IgGs against p-VEGFR2 and p-ERK. The membranes were then stripped and reprobed with IgGs against VEGFR2, ERK, and b-actin. Band intensities of p-VEGFR2 and p-ERK were normalized to the band intensities of VEGFR2 and ERK, respectively (*P < 0.05 versus PBS, #P < 0.05 versus VEGF only, n ¼ 3).

Article Snippet: After quenching endogenous peroxidase activity and blocking with 10% normal goat serum, tissue sections were incubated with primary IgGs against p-VEGFR2 (Origene) or glial fibrillary acidic protein (GFAP; Dako), and then incubated with the appropriate fluorescent secondary IgG.

Techniques: Phospho-proteomics, Western Blot

FIGURE 3. Intravitreal injection of apatinib decreases retinal neovascularization in mice with OIR. (A) Schematic diagram of the OIR experiment. On P12, mice received a single intravitreal injection of apatinib (1 lg in 1 lL DMSO) or DMSO (1 lL; contralateral control). Five days later (on P17), the eyes were harvested for further analysis. (B) Representative images of whole-mounted retinas with neovascular tufts highlighted in white, and quantification of retinal neovascularization. Retinal vasculature was visualized by staining with isolectin B4 (red). The extent of retinal neovascularization was calculated by dividing the number of pixels in the neovascular tuft area by the number of pixels in the total retinal area. All data are presented as the mean 6 SEM (**P < 0.01, n ¼ 4 mice per group). Scale bar: 500 lm. (C) Immunofluorescence staining was performed using anti-p-VEGFR2 IgGs (green) and isolectin B4 (red) on cryosections prepared from the eyecups of mice with OIR. The arrowheads indicate the double labeling of p-VEGFR2 and isolectin B4. Sections stained with irrelevant nonspecific IgGs are included as negative controls (NC). The nuclei are shown in blue (DAPI). Representative images were selected from three independent experiments with similar results. Scale bar: 50 lm.

Journal: Investigative ophthalmology & visual science

Article Title: Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.

doi: 10.1167/iovs.17-21416

Figure Lengend Snippet: FIGURE 3. Intravitreal injection of apatinib decreases retinal neovascularization in mice with OIR. (A) Schematic diagram of the OIR experiment. On P12, mice received a single intravitreal injection of apatinib (1 lg in 1 lL DMSO) or DMSO (1 lL; contralateral control). Five days later (on P17), the eyes were harvested for further analysis. (B) Representative images of whole-mounted retinas with neovascular tufts highlighted in white, and quantification of retinal neovascularization. Retinal vasculature was visualized by staining with isolectin B4 (red). The extent of retinal neovascularization was calculated by dividing the number of pixels in the neovascular tuft area by the number of pixels in the total retinal area. All data are presented as the mean 6 SEM (**P < 0.01, n ¼ 4 mice per group). Scale bar: 500 lm. (C) Immunofluorescence staining was performed using anti-p-VEGFR2 IgGs (green) and isolectin B4 (red) on cryosections prepared from the eyecups of mice with OIR. The arrowheads indicate the double labeling of p-VEGFR2 and isolectin B4. Sections stained with irrelevant nonspecific IgGs are included as negative controls (NC). The nuclei are shown in blue (DAPI). Representative images were selected from three independent experiments with similar results. Scale bar: 50 lm.

Article Snippet: After quenching endogenous peroxidase activity and blocking with 10% normal goat serum, tissue sections were incubated with primary IgGs against p-VEGFR2 (Origene) or glial fibrillary acidic protein (GFAP; Dako), and then incubated with the appropriate fluorescent secondary IgG.

Techniques: Injection, Control, Staining, Labeling

FIGURE 4. Intravitreal injection of apatinib decreases CNV formation in mice with laser-induced CNV. (A) Schematic diagram of the laser-induced CNV experiment. Immediately after laser photocoagulation, mice received a single intravitreal injection of apatinib (1 lg in 1 lL DMSO) or DMSO (1 lL; contralateral control). Two weeks later, the eyes were harvested for further analysis. (B) Representative images of flat-mounted choroids with CNV and quantification of the isolectin B4–positive CNV area. The posterior eyecups composed of RPE, choroid, and sclera were flat-mounted and stained with isolectin B4 (red). The CNV areas were quantified by measuring the fluorescence intensity of images with isolectin B4–positive areas. All data are presented as the mean 6 SEM (**P < 0.01, n¼4 mice per group). (C) Immunofluorescence staining was performed using anti-p-VEGFR2 IgGs (green) and isolectin B4 (red) on cryosections prepared from the eyecups of mice with CNV. The arrowheads indicate the double labeling of p- VEGFR2 and isolectin B4 in CNV lesions (white dashed circles). Sections stained with irrelevant nonspecific IgGs are included as negative controls (NC). The nuclei are shown in blue (DAPI). Representative images were selected from three independent experiments with similar results. Scale bars: 100 lm.

Journal: Investigative ophthalmology & visual science

Article Title: Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.

doi: 10.1167/iovs.17-21416

Figure Lengend Snippet: FIGURE 4. Intravitreal injection of apatinib decreases CNV formation in mice with laser-induced CNV. (A) Schematic diagram of the laser-induced CNV experiment. Immediately after laser photocoagulation, mice received a single intravitreal injection of apatinib (1 lg in 1 lL DMSO) or DMSO (1 lL; contralateral control). Two weeks later, the eyes were harvested for further analysis. (B) Representative images of flat-mounted choroids with CNV and quantification of the isolectin B4–positive CNV area. The posterior eyecups composed of RPE, choroid, and sclera were flat-mounted and stained with isolectin B4 (red). The CNV areas were quantified by measuring the fluorescence intensity of images with isolectin B4–positive areas. All data are presented as the mean 6 SEM (**P < 0.01, n¼4 mice per group). (C) Immunofluorescence staining was performed using anti-p-VEGFR2 IgGs (green) and isolectin B4 (red) on cryosections prepared from the eyecups of mice with CNV. The arrowheads indicate the double labeling of p- VEGFR2 and isolectin B4 in CNV lesions (white dashed circles). Sections stained with irrelevant nonspecific IgGs are included as negative controls (NC). The nuclei are shown in blue (DAPI). Representative images were selected from three independent experiments with similar results. Scale bars: 100 lm.

Article Snippet: After quenching endogenous peroxidase activity and blocking with 10% normal goat serum, tissue sections were incubated with primary IgGs against p-VEGFR2 (Origene) or glial fibrillary acidic protein (GFAP; Dako), and then incubated with the appropriate fluorescent secondary IgG.

Techniques: Injection, Control, Staining, Labeling

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Human Pluripotent Stem Cell-Derived Multipotent Vascular Progenitors of the Mesothelium Lineage Have Utility in Tissue Engineering and Repair

doi: 10.1016/j.celrep.2019.02.016

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit Polyclonal anti-Flk1-1 , Acris Antibodies GmbH , Cat# AP02618PU-S; RRID: AB_1624459.

Techniques: Control, Recombinant, Clinical Proteomics, Modification, Membrane, Sterility, Reverse Transcription, DNA Methylation Assay, Flow Cytometry, Methylation, Software, Imaging, Cell Culture